Fetal Hydrops and Immune Hemolytic Disease

Fetal hydrops is the abnormal accumulation of fluid in two or more fetal compartments, and immune hemolytic disease of the fetus and newborn is one of its classic causes, in which maternal antibodies cross the placenta and destroy fetal red cells. Together they illustrate how a single pathophysiological pathway, fetal anemia, can culminate in life-threatening fluid overload.

Definition

Hydrops fetalis is the pathological accumulation of fluid in at least two fetal compartments (such as skin edema, ascites, pleural effusion, or pericardial effusion), and immune hemolytic disease of the fetus and newborn is hydrops or anemia caused by maternal alloantibodies (classically anti-RhD) that cross the placenta and hemolyze fetal red cells.

Scope

The entry covers the definition of hydrops and its division into immune and non-immune forms, the mechanism of red-cell alloimmunization, the noninvasive detection of fetal anemia by middle cerebral artery Doppler, and the role of RhD immune globulin in prevention. It is a reference topic and does not provide treatment protocols.

Core questions

• What distinguishes immune from non-immune hydrops fetalis?
• How does maternal red-cell alloimmunization lead to fetal anemia and hydrops?
• How can fetal anemia be detected noninvasively?
• How has RhD immunoprophylaxis changed the epidemiology of the disease?

Key concepts

• Hydrops fetalis (immune versus non-immune)
• Red-cell alloimmunization
• Hemolytic disease of the fetus and newborn
• Fetal anemia
• Middle cerebral artery peak systolic velocity
• Amniotic fluid spectrophotometry (Liley curve)
• RhD immune globulin prophylaxis

Mechanisms

In immune hemolytic disease, a sensitized mother produces IgG antibodies against a fetal red-cell antigen she lacks (most importantly RhD); these antibodies cross the placenta and destroy fetal erythrocytes, producing anemia. Progressive anemia drives compensatory extramedullary hematopoiesis and, when severe, high-output cardiac failure, hepatic dysfunction, and reduced oncotic pressure that together cause the multi-compartment fluid accumulation defining hydrops. Fetal anemia can be inferred noninvasively from an elevated middle cerebral artery peak systolic velocity, which reflects the increased blood flow velocity of anemic blood (Mari et al., 2000).

Clinical relevance

Recognizing hydrops and the alloimmunized pregnancy underlies antenatal surveillance for fetal anemia and the prevention of hemolytic disease, and understanding these entities supports appraisal of fetal-medicine evidence. This entry describes mechanisms and detection; it is not a basis for individual decisions about surveillance, transfusion, or immunoprophylaxis.

Epidemiology

Routine RhD immune globulin prophylaxis has markedly reduced red-cell alloimmunization and its severe sequelae in higher-income settings, so that non-immune causes now account for the majority of hydrops in those populations, while immune hemolytic disease remains an important cause where prophylaxis is less available (ACOG, 2017; Norton et al., 2015).

Evidence & guidelines

A randomized trial established that middle cerebral artery Doppler is at least as accurate as amniocentesis for predicting severe fetal anemia, shifting practice away from invasive amniotic fluid spectrophotometry (Oepkes et al., 2006; building on Mari et al., 2000). SMFM provides guidance on the evaluation of non-immune hydrops (Norton et al., 2015), and ACOG addresses prevention of RhD alloimmunization (ACOG, 2017).

History

Amniotic fluid spectrophotometry, introduced by Liley in 1961, long guided the management of rhesus-sensitized pregnancies by estimating the severity of hemolysis. The advent of RhD immune globulin transformed the field by preventing most sensitization, and from 2000 onward middle cerebral artery Doppler displaced invasive testing for detecting fetal anemia (Liley, 1961; Mari et al., 2000; Oepkes et al., 2006).

Key figures

• A. William Liley
• Giancarlo Mari

Seminal works

• liley-1961
• mari-2000
• oepkes-2006

Frequently asked questions

What is the difference between immune and non-immune hydrops?

Immune hydrops is caused by maternal antibodies that hemolyze fetal red cells, producing anemia; non-immune hydrops encompasses the many other causes, such as cardiac, chromosomal, infectious, and structural conditions, and now accounts for most hydrops where RhD prophylaxis is routine.

How can fetal anemia be detected without an invasive procedure?

An elevated peak systolic velocity in the fetal middle cerebral artery on Doppler ultrasound reflects the faster flow of anemic blood and predicts significant fetal anemia, allowing detection without amniocentesis.